I have been following the Pharmaceutical sector since I was first introduced to equity trading 7 years ago. I purchased a company called JAZZ Pharmaceuticals at an average PPS of $1.42 per share. I noticed later that day the stock had doubled and quickly closed my position realizing a very nice return. Since then the company climbed to over $50 per share! This caught my attention and I became infatuated with the wild volatility of biotechnology companies and the achievable 10x return’s from strong plays. Today I am focused on analyzing various option strategies that make use of the drastic volatility of bio-tech companies targeted around the release of Phase 1, Phase 2, Phase 3 trials, as well as PDUFA decisions.